Sunshine Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 1,667.5% | 1,667.5% | -5,429.3% |
| FY2017 | 181.4% | 181.4% | -404.0% |
| FY2018 | 3,867.3% | 3,867.3% | -188.1% |
| FY2019 | 225.8% | 225.8% | -1,691.7% |
| FY2020 | 291.6% | 291.6% | -266.3% |
| FY2021 | -5,875.6% | -5,875.6% | -564.6% |
| FY2022 | -123.7% | -123.7% | -91.5% |
| FY2023 | -21.2% | -21.2% | -16.5% |
| FY2024 | -21.8% | -21.8% | -16.8% |
| FY2025 | -25.9% | -25.9% | -19.9% |